Nerve Growth Factor Completed Phase 2 Trials for HIE - Hypoxic - Ischemic Encephalopathy Prevention

Indications	Status	Purpose	Phase
DBCOND0136875 (HIE - Hypoxic - Ischemic Encephalopathy)	Completed	Prevention	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01059461	Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy	Cerebrolysin (DB16599) Nerve Growth Factor (DB12620)